
Cory L Gamble DO FACOI, FACE
Diabetes, Lipid Metabolism
US Medical Lead Victoza
Join to View Full Profile
6801 Rogers AveFort Smith, AR 72903
Phone+1 479-452-2077
Dr. Gamble is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of Oklahoma Health Sciences CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1985 - 1987
- Oklahoma State University Center for Health SciencesClass of 1982
Certifications & Licensure
- OK State License 1984 - 2023
- AR State License 1983 - 2021
Publications & Presentations
PubMed
- Persistence with once-weekly glucagon-like peptide 1 receptor agonist therapy decreases the risk of major adverse cardiovascular events: A retrospective analysis of pa...Tyler J Dunn, Yong Zhu, Noelle N Gronroos, Lin Xie, Andrew Sargent
Diabetes Research and Clinical Practice. 2025-05-01 - Once-Weekly Semaglutide Versus Sodium-Glucose Co-transporter 2 Inhibitors: Real-World Impact on Weight, HbA1c, and Healthcare Resource Utilization in Type 2 Diabetes (...James Amamoo, Riddhi Doshi, Joshua Noone, Lin Xie, Cory Gamble
Diabetes Therapy. 2025-05-01 - 1 citationsReal-world HbAchanges and prescription characteristics among type 2 diabetes mellitus patients initiating treatment with once weekly semaglutide for diabetes.Monica Frazer, Caroline Swift, Andrew Sargent, Michael Leszko, Erin Buysman
Journal of Diabetes and Metabolic Disorders. 2024-06-01
Professional Memberships
- Member
Industry Relationships
- US Medical Director Victoza, Novo Nordisk Inc2008 - 2014
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: